France says it may emulate Italy's move to block coronavirus vaccine exports outside the European Union if that is what is needed to enforce the bloc's own contracts with drugs manufacturers.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
The European Union defended the Italian authorities' decision to stop a large shipment of doses destined for Australia as part of a long-standing feud with drug manufacturer AstraZeneca and Germany.
The EU's executive arm said the decision was not targeting Australia but that it had been taken to ensure that AstraZeneca delivers the number of doses it committed to dispatching to EU countries.
"The fact is that the European Union is a major exporter of vaccine doses," EU Commission chief spokesman Eric Mamer said.
Faced with dose shortages during the early stages of the vaccine campaign, the EU announced in early January an export control mechanism halting deliveries of COVID-19 vaccines outside the bloc in a bid to force companies to respect their contractual obligations to the bloc first.
Since the mechanism entered into force on January 30, the Commission said that 174 authorisations of vaccine exports to 30 different countries outside the EU have been approved.
The EU has been particularly upset by AstraZeneca because the company is delivering far fewer doses to the bloc than it had promised.
Of the initial order for 80 million doses to the EU in the first quarter this year, the company will be struggling to deliver half that quantity.
"We believe that this vaccine is an important element of our portfolio and we therefore are expecting the delivery of the agreed doses," Mamer said.
"We are working with the companies in order to ensure that they deliver the doses that are foreseen for the European Union. For all those companies that are doing that, there are no problem with exports."
Australian Associated Press
